Arrowhead Research | ARWR - Passifs Courants





Passifs Courants Changement Date
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 311.34M 27.99M 2026-09
Heron Therapeutics USD 89.85M 2.3M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ionis Pharmaceuticals USD 435.29M 119.65M 2026-09
Ligand Pharmaceuticals USD 500.57M 453.83M 2026-09
Merck USD 28.8B 1.07B 2026-09
Moderna USD 2.03B 506M 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novartis USD 32.52B 777M 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
TG Therapeutics USD 260.53M 7.97M 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09
Xencor USD 76.27M 5.6M 2026-09